PMC:7205724 / 35-150
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 97-112 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 54-78 | Chemical | denotes | immunosuppressive agents | http://purl.obolibrary.org/obo/CHEBI_35705 |
LitCovid-sample-MedDRA
| Id | Subject | Object | Predicate | Lexical cue | meddra_id |
|---|---|---|---|---|---|
| T1 | 97-112 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | immunoglobulins | http://purl.bioontology.org/ontology/MEDDRA/10021496 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 54-71 | http://purl.obolibrary.org/obo/IDO_0000610 | denotes | immunosuppressive |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 5-79 | Sentence | denotes | Rationale and hypothesis for the use of multiple immunosuppressive agents: |
LitCovid-sample-Enju
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 3-4 | -COLON- | denotes | : |
| T6 | 5-14 | NN | denotes | Rationale |
| T7 | 15-18 | CC | denotes | and |
| T8 | 19-29 | NN | denotes | hypothesis |
| T9 | 30-33 | IN | denotes | for |
| T10 | 34-37 | DT | denotes | the |
| T11 | 38-41 | NN | denotes | use |
| T12 | 42-44 | IN | denotes | of |
| T13 | 45-53 | JJ | denotes | multiple |
| T14 | 54-71 | JJ | denotes | immunosuppressive |
| T15 | 72-78 | NNS | denotes | agents |
| T16 | 78-79 | -COLON- | denotes | : |
| T17 | 80-95 | NNS | denotes | Anti-antibodies |
| T18 | 95-96 | -COMMA- | denotes | , |
| T19 | 97-112 | NNS | denotes | immunoglobulins |
| T20 | 112-113 | -COMMA- | denotes | , |
| R5 | T6 | T7 | arg1Of | Rationale,and |
| R6 | T8 | T7 | arg2Of | hypothesis,and |
| R7 | T7 | T9 | arg1Of | and,for |
| R8 | T11 | T9 | arg2Of | use,for |
| R9 | T11 | T10 | arg1Of | use,the |
| R10 | T11 | T12 | arg1Of | use,of |
| R11 | T15 | T12 | arg2Of | agents,of |
| R12 | T15 | T13 | arg1Of | agents,multiple |
| R13 | T15 | T14 | arg1Of | agents,immunosuppressive |
| R14 | T7 | T16 | arg1Of | and,: |
| R15 | T17 | T18 | arg1Of | Anti-antibodies,"," |
| R16 | T19 | T18 | arg2Of | immunoglobulins,"," |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 97-112 | Body_part | denotes | immunoglobulins | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 5-79 | Sentence | denotes | Rationale and hypothesis for the use of multiple immunosuppressive agents: |